The Global Retinal Implant Market is Projected to Exceed $74 Million by 2026, Driven by the Increasing Prevalence of Target Diseases and Rising Geriatric Population
DUBLIN, Nov. 19, 2018 /PRNewswire/ --
The "Retinal Implant Market Size, Share & Trends Analysis Report By Device Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, and Argus II), By Region, And Segment Forecasts, 2018 - 2026" report has been added to ResearchAndMarkets.com's offering.
The global retinal implant market size is expected to reach USD 74.7 million by 2026. It is projected to expand at a CAGR of 10.6% over the forecast period.
Increasing prevalence of target diseases, and rising geriatric population are the key driving factors for the market. Rising capability of restoring vision is anticipated to bode well for demand over the forecast period.
Laser therapy and Photodynamic Therapy (PTD) and some of the conventional treatments available for Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD). Drugs such as Lucentis, Macugen, Eylea, and Vitamin A are a part of therapeutic treatment. Such treatments aid in reducing disease progression and thereby, delaying blindness. However, none of these treatments can completely cure the disease and restore vision. As a result, treatment procedures that restore vision are highly in demand.
Currently approved devices are capable of restoring vision with the help of electrodes, camera chips, lenses, software, and other tools. Moreover, implantable miniature telescope, Argus II is easy to use and enables patients to carry out their daily activities with ease. Furthermore, these devices can be used for a prolonged period of time, eliminating the need for another surgery. Therefore, the capability of advanced implantable devices to restore vision is expected to propel the market growth in near future.
Increasing geriatric population and rising disposable income in developing economies such as Japan, China, and India are also expected to boost the retinal implant market over the forecast period. Moreover, increasing healthcare expenditure by governments and private sectors and initiatives by major market players to operate in untapped regions are also anticipated to propel the growth in the forthcoming years.
Further key findings from the study suggest:
- In terms of revenue, implantable miniature telescope segment is projected to expand at the highest CAGR over the forecast period. Increasing prevalence of AMD among geriatric population and usage of implantable devices to treat vision problems might drive the segment's growth over the forecast period
- In 2026, Asia-Pacific market is expected to witness the fastest CAGR over the forecast period owing to increasing geriatric population and disposable income
- VisionCare, Inc.; Retina Implant AG; and Second Sight Medical Products, Inc. are expected to dominate the retinal implant market over the forecast period.
Key Topics Covered
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.3.1. Region wise market: base estimates
2.3.2. Global market: CAGR calculation
2.4 Region Based Segment Share Calculation
2.5 List of Secondary Sources (Partial List)
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1. Rising prevalence of target diseases
3.2.2. Capability of restoring vision
3.3 Market Restraint Analysis
3.3.1. High cost of commercially available products
3.4 Penetration & Growth Prospect Mapping: Device Type
3.5 Retinal Implant Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Growth Potential by Target Condition
3.7 Product Development: Clinical Trial Overview
Chapter 4 Device Type Estimates & Trend Analysis
4.1 Retinal Implant Market: Device Type Movement Analysis
4.2 Retina Implant Alpha AMS
4.3 ImplanTable Miniature Telescope (IMT)
4.4 Argus II
4.5 Others
Chapter 5 Regional Estimates & Trend Analysis, by Device Type
5.1 Retinal Implant Market Share By Region, 2017 & 2026
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 MEA
Chapter 6 Competitive Landscape
6.1 Company Profiles
- Second Sight Medical Products, Inc.
- Retina Implant AG
- VisionCare, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/n4vcpl/the_global?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article